Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2QVS

Crystal Structure of Type IIa Holoenzyme of cAMP-dependent Protein Kinase

Summary for 2QVS
Entry DOI10.2210/pdb2qvs/pdb
Related1cx4 1rgs 1u7e
DescriptorcAMP-dependent protein kinase, alpha-catalytic subunit, cAMP-dependent protein kinase type II-alpha regulatory subunit (3 entities in total)
Functional Keywordscamp-dependent protein kinase, type iia holoenzyme, isoform diversity, alternative splicing, atp-binding, cytoplasm, lipoprotein, myristate, nucleotide-binding, nucleus, phosphorylation, serine/threonine-protein kinase, transferase, acetylation, camp-binding, transferase-transferase regulator complex, transferase/transferase regulator
Biological sourceMus musculus (house mouse)
More
Cellular locationCytoplasm (By similarity): P05132
Total number of polymer chains2
Total formula weight75958.33
Authors
Wu, J.,Brown, S.H.J.,von Daake, S.,Taylor, S.S. (deposition date: 2007-08-08, release date: 2007-10-23, Last modification date: 2024-10-30)
Primary citationWu, J.,Brown, S.H.J.,von Daake, S.,Taylor, S.S.
PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity.
Science, 318:274-279, 2007
Cited by
PubMed Abstract: The catalytic (C) subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is inhibited by two classes of regulatory subunits, RI and RII. The RII subunits are substrates as well as inhibitors and do not require adenosine triphosphate (ATP) to form holoenzyme, which distinguishes them from RI subunits. To understand the molecular basis for isoform diversity, we solved the crystal structure of an RIIalpha holoenzyme and compared it to the RIalpha holoenzyme. Unphosphorylated RIIalpha(90-400), a deletion mutant, undergoes major conformational changes as both of the cAMP-binding domains wrap around the C subunit's large lobe. The hallmark of this conformational reorganization is the helix switch in domain A. The C subunit is in an open conformation, and its carboxyl-terminal tail is disordered. This structure demonstrates the conserved and isoform-specific features of RI and RII and the importance of ATP, and also provides a new paradigm for designing isoform-specific activators or antagonists for PKA.
PubMed: 17932298
DOI: 10.1126/science.1146447
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon